Form 4 for XFOR X4 Pharmaceuticals, Inc
Accepted 2025-08-14 00:00:00 ET · period of report 2025-08-12 · accession 0001628280-25-040440 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-14 | 2025-08-14 | XFOR | KIRSKE DAVID | CFO | A - Grant | $0.00 | +193.3K | 193.3K | New | $0 |
| DM | 2025-08-14 | 2025-08-12+ | XFOR | KIRSKE DAVID | CFO | A - Grant | $0.00 | +1.43M | 1.07M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-14 | A | A | 193,254 | $0.00 | 193,254 | D | — | — | (F1) Represents restricted stock units (RSUs) granted to the Reporting Person. One third of the RSUs shall vest on February 12, 2026, with the remainder vesting in equal installments in each successive quarter thereafter for a period of 12 months, subject to the Reporting Person continuing to provide services through each such date and contingent upon approval of the grant at the Issuer's 2026 Annual Meeting of Stockholders. |
| 2 | Derivative | Stock Option (right to buy) | 2025-08-14 | A | A | 352,800 | $0.00 | 352,800 | D | $3.14 · — to 2035-08-14 | 352,800 Common Stock | (F2) One half of the shares subject to the option shall vest on February 12, 2026, with the remainder vesting in equal installments in each successive month thereafter for a period of 12 months, subject to the Reporting Person continuing to provide services through each such date; provided that one half of the shares subject to the option shall vest immediately upon achievement of certain performance-based milestones prior to February 12, 2026. |
| 3 | Derivative | Stock Option (right to buy) | 2025-08-12 | A | A | 1,073,249 | $0.00 | 1,073,249 | D | $1.42 · — to 2035-08-12 | 1,073,249 Common Stock | (F2) One half of the shares subject to the option shall vest on February 12, 2026, with the remainder vesting in equal installments in each successive month thereafter for a period of 12 months, subject to the Reporting Person continuing to provide services through each such date; provided that one half of the shares subject to the option shall vest immediately upon achievement of certain performance-based milestones prior to February 12, 2026. |